By 2030, the bone graft substitute market is predicted to reach USD 2,121.66 million, registering a CAGR of 6.80% during the forecast period.

Market Research Future (MRFR) has published a cooked research report onthe “Global Bone Graft Substitute Market” that contains the information from  2022-2030.

The Bone Graft Substitute Market is projected to reach USD 2,121.66 million by 2030 at 6.80% CAGR during the forecast period 2022-2030.

Implantable materials called bone grafts are used in surgical procedures to promote bone growth, healing, and osseous reconstruction. In place of autogenous or allogenous bone, a bone substitute is a synthetic, inorganic, or biologically organic mixture that can correct a bone deficiency. The development of biocompatible synthetic bone grafts, increased demand for oral bone graft treatments, and increased road injury and joint condition incidences are key drivers driving market expansion. Bone graft substitute market trends will expand, but it is hindered by factors like high surgical expenses, dangers associated with bone graft treatments, and complications.

One of the reasons for the bone graft substitute market growth is the frequency of traffic accidents. For instance, the WHO estimates that 1.35 million people die yearly in road accidents, and 20 to 50 million people suffer non-fatal injuries. Additionally, the National Trauma Institute estimates that the economic toll of trauma cases in 2014 grew to USD 671 billion, including lost productivity and hospital expenditures. There are several ways to treat diseases and injuries with bone grafting. It may be used if a fracture has poor healing after initial therapy. In a sick joint, it is also utilized for fusion, which aids in the recovery of two bones. Spinal fusion is most frequently performed. Another influencing driver for the market is the development of biocompatible synthetic bone transplants. Furthermore, more people need dental bone transplants.

Regional Analysis

North America and Latin America are subdivided further into the Americas. The US and Canada make up the second division of the North American market. Numerous reasons, including the prevalence of significant major companies and the high frequency of orthopedic procedures, have contributed to North America holding the most critical market share.

According to the bone graft substitute market analysis, Europe accounted for a sizeable portion of the global market for bone graft substitutes. With the increased knowledge of alternatives to bone grafts and the rising cost of healthcare, Europe has developed into a significant market. The area has considerable growth potential, which will aid in the future growth of the global market. It is anticipated that nations like the UK and Germany will significantly contribute to developing the regional market, which will be advantageous to the sector.

The bone graft substitute market is predicted to develop fastest in Asia-Pacific. Due to the presence of developing economies like India, China, and South Korea and the growing prospective patient population, the area offers lucrative opportunities for companies in the bone graft substitute market.

A growing number of research firms and subsidiaries engaged in R&D and increased efforts by Middle Eastern nations to strengthen their healthcare infrastructure are driving the Middle East, and African bone graft substitutes market to substantiate bone replacement graft growth.

Explore In-depth Details: Bone Graft Substitute Market Research Report

Market Segmentation

The market segmentation for biomarkers is as follows:

• By product type


• By application type

Based on the product type, the market is segmented into:

• Allograft, Bone Graft


• Substitute


• Cell-based Matrices

Under application, bone replacement graft is divided into Spinal Fusion, Joint Reconstruction, Long Bone, Dental, Foot & Ankle.

Key Players

The key players in the bone graft substitute market are:

• ACE Surgical Supply Company


• (US)


• BioHorizons (US)


• Dentium (South Korea)


• Dentsply Sirona (US)


• Institut Straumann AG (Switzerland)


• Medtronic (Ireland)


• Stryker (US)


• Zimmer Biomet (US)